LAIR1 and systemic lupus erythematosus: The role of LAIR-1 in chronic inflammatory processes, such as rheumatoid arthritis [16] and systemic lupus erythematosus [17], suggest that LAIR-1, as an inhibitory receptor, may contribute to the pathophysiology of post-chronic inflammation, including post-HCV.